Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.390
+0.030 (8.25%)
Sep 16, 2024, 3:59 PM EDT
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had revenue of $18.80M in the quarter ending June 30, 2024, with 109.39% growth. This brings the company's revenue in the last twelve months to $66.45M, up 87.38% year-over-year. In the fiscal year ending March 31, 2024, Elite Pharmaceuticals had annual revenue of $56.63M with 65.79% growth.
Revenue (ttm)
66.45M
Revenue Growth
+87.38%
P/S Ratio
6.04
Revenue / Employee
1.04M
Employees
64
Market Cap
416.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
| Mar 31, 2020 | 17.99M | 10.43M | 137.76% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 920.97M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 108.78M |
Elite Pharmaceuticals News
- 20 days ago - Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium - Newsfile Corp
- 4 weeks ago - Elite Pharmaceuticals, Inc. (ELTP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Elite Pharmaceuticals reports Q1 results - Seeking Alpha
- 4 weeks ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information - Newsfile Corp
- 5 weeks ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024 - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals, Inc. (ELTP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024 - Newsfile Corp